Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 37 of FATE THERAPEUTICS INC's SEC filings and found 2 warrant series, 1 convertible, 1 ATM program and 2 shelf registrations on file for FATE. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CAMPCAMP4 Therapeutics Corporation
ABEOAbeona Therapeutics Inc.
CABACabaletta Bio, Inc.
IFRXInflaRx N.V. Common Stock
OCGNOcugen, Inc.
LXEOLexeo Therapeutics, Inc. Common Stock
GLSIGreenwich LifeSciences, Inc.
IMRXImmuneering Corporation
LCTXLineage Cell Therapeutics, Inc.
QTTBQ32 Bio Inc.
LRMRLarimar Therapeutics, Inc.
LYELLyell Immunopharma, Inc.
VNDAVanda Pharmaceuticals Inc.
BIOABioAge Labs Inc.
KRROKorro Bio, Inc.